Reuters - Software maker Oracle Corp is set to buy drug data management software company Phase Forward for about $685 million, aiming to bolster its health sciences business.
Source
Reuters - Software maker Oracle Corp is set to buy drug data management software company Phase Forward for about $685 million, aiming to bolster its health sciences business.
Source